Communicable Disease Report 2011

Total Page:16

File Type:pdf, Size:1020Kb

Communicable Disease Report 2011 Washington State COMMUNICABLE DISEASE REPORT 2011 For additional copies of this document or to obtain this document in an alternative format please contact: Washington State Department of Health Office of Communicable Disease Epidemiology 1610 NE 150th Street Shoreline, WA 98155 206.418.5500 or 1.877.539.4344 DOH 420-004 WASHINGTON STATE DEPARTMENT OF HEALTH Epidemiology, Health Statistics and Public Health Laboratories Communicable Disease Epidemiology 1610 NE 150th Street Shoreline, WA 98155 206-418-5500 or 1-877-539-4344 COMMUNICABLE DISEASE REPORT 2011 CONTRIBUTORS COMMUNICABLE DISEASE EPIDEMIOLOGY Mary Chadden Natasha Close, MPH Marisa D’Angeli, MD, MPH Chas DeBolt, RN, MPH Marcia Goldoft, MD, MPH, MS Kathy Lofy, MD Kathryn MacDonald, PhD Nicola Marsden-Haug, MPH Jasmine Matheson, MPH Kathleen Stigi, MPH Tracy Sandifer, MPH Azadeh Tasslimi, MPH Doreen Terao Sherryl Terletter Wayne Turnberg, PhD, MSPH DISEASE CONTROL AND HEALTH STATISTICS Maria Courogen, MPH Jennifer Reuer, MPH Shawn McBrien, MPH Tom Jaenicke, MPH, MBA, MES Julieann Simon, MSPH PREVENTION AND COMMUNITY HEALTH Shana Johnny, RN, MN i Mary Selecky Secretary of Health Maxine Hayes, MD, MPH Health Officer Jennifer Tebaldi, MBA, RS Assistant Secretary Disease Control and Health Statistics Wayne Turnberg, PhD, MSPH Director for the Office of Communicable Disease Epidemiology Maria Courogen, MPH Director for the Office of Infectious Disease Vacant State Epidemiologist for Communicable Disease Romesh Gautom, PhD Director, Public Health Laboratories Juliet VanEenwyk, PhD, MS State Epidemiologist for Non-Infectious Disease This report represents Washington State communicable disease surveillance: the ongoing collection, analysis and dissemination of morbidity and mortality data to prevent and control communicable disease. In addition to the contributors listed on the previous page, we would like to recognize the staff of the Washington State Public Health Laboratories, the staff of Washington’s local health jurisdictions who contribute to surveillance, investigation, and prevention of communicable diseases in our state, and the thousands of people in clinics, hospitals and clinical laboratories throughout Washington whose disease reports constitute the basis for this document. Revised January 2013 ii Table of Contents Executive Summary – 2011 .................................................................................................................................... v Technical Notes ...................................................................................................................................................... v Reporting a Notifiable Condition........................................................................................................................... vi Arboviral Disease.................................................................................................................................................... 3 West Nile Virus (WNV) Disease ......................................................................................................................... 3 Yellow Fever ....................................................................................................................................................... 4 Botulism .................................................................................................................................................................. 4 Brucellosis............................................................................................................................................................... 5 Campylobacteriosis ................................................................................................................................................. 5 Chlamydia Infection................................................................................................................................................ 6 Cholera .................................................................................................................................................................... 6 Cryptosporidiosis .................................................................................................................................................... 6 Cyclosporiasis ......................................................................................................................................................... 7 Diphtheria ............................................................................................................................................................... 7 Giardiasis ................................................................................................................................................................ 8 Gonorrhea ............................................................................................................................................................... 8 Haemophilus influenzae (Invasive Disease, Under Age 5 Years) .......................................................................... 8 Hantavirus Pulmonary Syndrome (HPS) ................................................................................................................ 9 Hepatitis A .............................................................................................................................................................. 9 Hepatitis B ............................................................................................................................................................ 10 Hepatitis C ............................................................................................................................................................ 10 Hepatitis D or E .................................................................................................................................................... 11 Herpes Simplex, Genital and Neonatal ................................................................................................................. 11 HIV/AIDS ............................................................................................................................................................. 12 Legionellosis ......................................................................................................................................................... 12 Leptospirosis ......................................................................................................................................................... 13 Listeriosis .............................................................................................................................................................. 13 Lyme Disease ........................................................................................................................................................ 14 Malaria .................................................................................................................................................................. 14 Measles ................................................................................................................................................................. 14 Meningococcal Disease (Invasive) ....................................................................................................................... 15 Mumps .................................................................................................................................................................. 16 Pertussis ................................................................................................................................................................ 16 Plague .................................................................................................................................................................... 17 Polio ...................................................................................................................................................................... 17 Psittacosis .............................................................................................................................................................. 18 Q Fever.................................................................................................................................................................. 18 Rabies (Human) .................................................................................................................................................... 19 Rabies, Suspected Human Exposure..................................................................................................................... 19 Rare Diseases of Public Health Significance ........................................................................................................ 23 Melioidosis ........................................................................................................................................................ 23 Coccidioidomycosis (Valley Fever) .................................................................................................................. 23 Creutzfeldt-Jakob Disease (CJD) ...................................................................................................................... 23 Cryptococcosis..................................................................................................................................................
Recommended publications
  • Transmission and Evolution of Tick-Borne Viruses
    Available online at www.sciencedirect.com ScienceDirect Transmission and evolution of tick-borne viruses Doug E Brackney and Philip M Armstrong Ticks transmit a diverse array of viruses such as tick-borne Bourbon viruses in the U.S. [6,7]. These trends are driven encephalitis virus, Powassan virus, and Crimean-Congo by the proliferation of ticks in many regions of the world hemorrhagic fever virus that are reemerging in many parts of and by human encroachment into tick-infested habitats. the world. Most tick-borne viruses (TBVs) are RNA viruses that In addition, most TBVs are RNA viruses that mutate replicate using error-prone polymerases and produce faster than DNA-based organisms and replicate to high genetically diverse viral populations that facilitate their rapid population sizes within individual hosts to form a hetero- evolution and adaptation to novel environments. This article geneous population of closely related viral variants reviews the mechanisms of virus transmission by tick vectors, termed a mutant swarm or quasispecies [8]. This popula- the molecular evolution of TBVs circulating in nature, and the tion structure allows RNA viruses to rapidly evolve and processes shaping viral diversity within hosts to better adapt into new ecological niches, and to develop new understand how these viruses may become public health biological properties that can lead to changes in disease threats. In addition, remaining questions and future directions patterns and virulence [9]. The purpose of this paper is to for research are discussed. review the mechanisms of virus transmission among Address vector ticks and vertebrate hosts and to examine the Department of Environmental Sciences, Center for Vector Biology & diversity and molecular evolution of TBVs circulating Zoonotic Diseases, The Connecticut Agricultural Experiment Station, in nature.
    [Show full text]
  • Clinically Important Vector-Borne Diseases of Europe
    Natalie Cleton, DVM Erasmus MC, Rotterdam Department of Viroscience [email protected] No potential conflicts of interest to disclose © by author ESCMID Online Lecture Library Erasmus Medical Centre Department of Viroscience Laboratory Diagnosis of Arboviruses © by author Natalie Cleton ESCMID Online LectureMarion Library Koopmans Chantal Reusken [email protected] Distribution Arboviruses with public health impact have a global and ever changing distribution © by author ESCMID Online Lecture Library Notifications of vector-borne diseases in the last 6 months on Healthmap.org Syndromes of arboviral diseases 1) Febrile syndrome: – Fever & Malaise – Headache & retro-orbital pain – Myalgia 2) Neurological syndrome: – Meningitis, encephalitis & myelitis – Convulsions & coma – Paralysis 3) Hemorrhagic syndrome: – Low platelet count, liver enlargement – Petechiae © by author – Spontaneous or persistent bleeding – Shock 4) Arthralgia,ESCMID Arthritis and Online Rash: Lecture Library – Exanthema or maculopapular rash – Polyarthralgia & polyarthritis Human arboviruses: 4 main virus families Family Genus Species examples Flaviviridae flavivirus Dengue 1-5 (DENV) West Nile virus (WNV) Yellow fever virus (YFV) Zika virus (ZIKV) Tick-borne encephalitis virus (TBEV) Togaviridae alphavirus Chikungunya virus (CHIKV) O’Nyong Nyong virus (ONNV) Mayaro virus (MAYV) Sindbis virus (SINV) Ross River virus (RRV) Barmah forest virus (BFV) Bunyaviridae nairo-, phlebo-©, orthobunyavirus by authorCrimean -Congo heamoragic fever (CCHFV) Sandfly fever virus
    [Show full text]
  • When Neglected Tropical Diseases Knock on California's Door
    When Neglected Tropical Diseases Knock on California’s Door Anne Kjemtrup, DVM, MPVM, PhD California Department of Public Health Vector-Borne Disease Section Overview of Today’s Topics • Neglected tropical diseases: setting the stage for impact on California • California Public Health Overview – Surveillance/response structure – Vector-Borne Disease program areas THE MONSTER RETURNS • Two examples: Peter McCarty – Arbovirus introduction (dengue, chikungunya, zika) – Re-emergence of Rocky Mountain spotted fever (not really NTD but similar principals) Neglected Tropical Diseases* • Buruli Ulcer • Leishmaniasis • Chagas disease • Leprosy (Hansen disease) • Dengue and Chikungunya • Lymphatic filariasis • Dracunculiasis (guinea • Onchocerciasis (river worm disease) blindness) • Echinococcosis • Mycetoma • Endemic treponematoses • Rabies (Yaws) • Schistosomiasis • Foodborne trematodiases • Soil-transmitted • Human African helminthiases trypanosomiasis (sleeping • Taeniasis/Cysticercosis sickness) • Trachoma * from: http://www.who.int/neglected_diseases/diseases/en/ Neglected Tropical Diseases • Buruli Ulcer • Leishmaniasis • Chagas disease • Leprosy (Hansen disease) • Dengue and Chikungunya • Lymphatic filariasis • Dracunculiasis (guinea • Mycetoma worm disease) • Onchocerciasis (river • Echinococcosis blindness) • Endemic treponematoses • Rabies (Yaws) • Schistosomiasis • Foodborne trematodiases • Soil-transmitted • Human African helminthiases trypanosomiasis (sleeping • Taeniasis/Cysticercosis sickness) • Trachoma California has vector and/or
    [Show full text]
  • The Ecology of New Constituents of the Tick Virome and Their Relevance to Public Health
    viruses Review The Ecology of New Constituents of the Tick Virome and Their Relevance to Public Health Kurt J. Vandegrift 1 and Amit Kapoor 2,3,* 1 The Center for Infectious Disease Dynamics, Department of Biology, The Pennsylvania State University, University Park, PA 16802, USA; [email protected] 2 Center for Vaccines and Immunity, Research Institute at Nationwide Children’s Hospital, Columbus, OH 43205, USA 3 Department of Pediatrics, Ohio State University, Columbus, OH 43205, USA * Correspondence: [email protected] Received: 21 March 2019; Accepted: 29 May 2019; Published: 7 June 2019 Abstract: Ticks are vectors of several pathogens that can be transmitted to humans and their geographic ranges are expanding. The exposure of ticks to new hosts in a rapidly changing environment is likely to further increase the prevalence and diversity of tick-borne diseases. Although ticks are known to transmit bacteria and viruses, most studies of tick-borne disease have focused upon Lyme disease, which is caused by infection with Borrelia burgdorferi. Until recently, ticks were considered as the vectors of a few viruses that can infect humans and animals, such as Powassan, Tick-Borne Encephalitis and Crimean–Congo hemorrhagic fever viruses. Interestingly, however, several new studies undertaken to reveal the etiology of unknown human febrile illnesses, or to describe the virome of ticks collected in different countries, have uncovered a plethora of novel viruses in ticks. Here, we compared the virome compositions of ticks from different countries and our analysis indicates that the global tick virome is dominated by RNA viruses. Comparative phylogenetic analyses of tick viruses from these different countries reveals distinct geographical clustering of the new tick viruses.
    [Show full text]
  • Tick Talk: Advancing the Understanding and Prevention of Tick-Borne Diseases
    Tick Talk: Advancing the Understanding and Prevention of Tick-borne Diseases Seemay Chou UCSF Dept of Biochemistry & Biophysics Osher Mini Med School, 11/14/19 Malaria Sleeping sickness Lyme disease Topics: 1. Ticks and their vector capacity 2. Challenges associated with diagnosing Lyme 3. Strategies for blocking tick-borne diseases 4. What else can we learn from ticks? Ticks are vectors for human diseases Lyme Disease Ixodes scapularis Anaplasmosis Ixodes pacificus Babesiosis Powassan Disease Dermacentor andersoni Rocky Mountain Spotted Fever Dermacentor variablis Colorado Tick Fever Ehrlichiosis Amblyomma maculatum Rickettsiosis Amblyomma americanum Mammalian Meat Allergy Different ticks have different lifestyles Hard scutum Soft capitulum Ixodes scapularis Ornithodoros savignyi Different ticks have different lifestyles Hard • 3 stages: larvae, nymphs, adults • Single bloodmeal between each • Bloodmeal: days to over a week Ixodes scapularis Lyme disease cases in the U.S. are on the rise Ixodes scapularis Borrelia burgdorferi Lyme disease Cases have tripled in past decade Most commonly reported vector-borne disease in U.S. Centers for Disease Control Tick–pathogen relationships are remarkably specific Source: CDC.gov Lyme disease is restricted to where tick vectors are Source: CDC.gov West coast vector: Ixodes pacificus Western blacklegged tick West coast vector: Ixodes pacificus Sceloporus occidentalis Western fence lizard County level distribution of submitted Ixodes Nieto et al, 2018 Distribution of other tick species received Nieto
    [Show full text]
  • Healthcare Providers, Hospitals, Local Health Departments (Lhds)
    May 11, 2015 TO: Healthcare Providers, Hospitals, Local Health Departments (LHDs) FROM: NYSDOH Bureau of Communicable Disease Control HEALTH ADVISORY: TESTING AND REPORTING OF MOSQUITO- AND TICK-BORNE ILLNESSES For healthcare facilities, please distribute immediately to the Infection Control Department, Emergency Department, Infectious Disease Department, Director of Nursing, Medical Director, Laboratory Service, and all patient care areas. The New York State Department of Health (NYSDOH) is advising physicians on the procedures to test and report suspected cases of mosquito-borne illnesses, including West Nile virus (WNV), eastern equine encephalitis (EEE), dengue fever, and chikungunya as well as tick-borne illnesses including Lyme disease, babesiosis, anaplasmosis, ehrlichiosis, and Rocky Mountain spotted fever. SUMMARY Mosquito-borne (arboviral) illnesses: o During the mosquito season (early summer until late fall), health care providers should consider mosquito-borne infections in the differential diagnosis of any adult or pediatric patient with clinical evidence of viral encephalitis or viral meningitis. o All cases of suspected viral encephalitis should be reported immediately to the LHD. o Dengue and/or chikungunya should be suspected year round in patients presenting with fever, arthralgia, myalgia, rash, or other illness consistent with infection and recent travel to endemic areasi. o Wadsworth Center, the NYSDOH public health laboratory, provides testing for a number of domestic, exotic, common and rare viruses. The tests performed will depend on the clinical characteristics, patient status and travel history. Health care providers should contact the LHD of the patient’s county of residence prior to submission of specimens. Tick-borne illnesses: o Tick-borne disease symptoms vary by type of infection and can include fever, fatigue, headache, and rash.
    [Show full text]
  • Zoonoses of Importance in Wildlife Rehabilitation
    Zoonoses of Importance in Wildlife Rehabilitation Margaret A. Wild, Colorado Division of Wildlife, 317 W. Prospect Road, Fort Collins, Colorado 80526 W. John Pape, Colorado Department of Public Health and Environment, 4300 Cherry Creek Drive South, Denver, Colorado 80222-1530 Zoonoses are infections or infestations shared in nature by humans and other vertebrate animals. Because wildlife rehabilitators work with animals that have unknown health histories, may be ill, and may be more susceptible to disease due to the stress of captivity, there is a risk of exposure to zoonotic diseases. Although infection of wildlife with most zoonotic diseases is uncommon in Colorado, it is prudent to follow precautions when housing, handling, and treating wild species. In general, most problems can be avoided by using common sense and good hygiene practices. Prevention of infection with zoonotic diseases should be a major emphasis in protocols for rehabilitation of wildlife. In addition to specific control and prevention guidelines listed below for each group of diseases, some general guidelines should be followed in all cases. First, isolation of the wild animal is important both for the animal and to minimize exposure of humans to potential pathogens. Second, good personal hygiene is important. Handwashing after handling animals or animal facilities is extremely important. People should not consume food or drink in the animal facilities. Additional precautions may include wearing protective clothing (lab coat, coveralls), boots, gloves, and/or dust mask depending on the situation. Because children are more susceptible to some zoonotic diseases, particular emphasis should be placed on protecting children. Third, animal facilities and equipment should be kept clean.
    [Show full text]
  • Mark Woolhouse University of Edinburgh, UK
    WHAT WILL CAUSE THE NEXT PANDEMIC? Mark Woolhouse University of Edinburgh, UK With thanks to: Feifei Zhang, Lu Lu, Liam Brierley, Alistair Morrison, Tara Wagner-Gamble and many others WHAT WILL CAUSE THE NEXT PANDEMIC? The 2018 list of disease priorities needing urgent R&D attention comprises: Crimean-Congo haemorrhagic fever (CCHF) Ebola virus disease and Marburg virus disease Lassa fever MERS-CoV and SARS Nipah and henipaviral diseases Rift Valley fever (RVF) The possibility that a serious Zika international epidemic could be Disease X caused by a pathogen currently unknown to cause human disease Candidates included “highly pathogenic coronaviral diseases other than MERS and SARS” Mark Woolhouse, University of Edinburgh, September 2020 WHAT WILL CAUSE THE NEXT PANDEMIC? • Virus discovery • Known viruses • Disease X • Virus diversity • SARS-CoV-2 WHAT WILL CAUSE THE NEXT PANDEMIC? • Virus discovery • Known viruses • Disease X • Virus diversity • SARS-CoV-2 HUMAN PATHOGEN SURVEY • Systematic review of primary literature • Formal methodology → Taylor et al. (2001) Phil. Trans. B • 70% EIDs are zoonotic • 70% EIDs caused by RNA viruses 214 recognised RNA virus species (to 2015) 55 genera 21 families (+1 unassigned genus) Mark Woolhouse, University of Edinburgh, September 2020 RNA VIRUS DISCOVERY Mark Woolhouse, University of Edinburgh, September 2020 Woolhouse & Brierley (2018) Scientific Data PREDICTING WHERE Risk maps created using a boosted regression tree model with 33 predictors. Models trained on 223 discoveries worldwide and 83 in China. Top predictors: GDP/GDP growth > urbanisation > climate > biodiversity. Discoveries since 2015 indicated (black triangles) and location of Wuhan shown. Mark Woolhouse, University of Edinburgh, September 2020 Zhang et al.
    [Show full text]
  • Zoonotic Potential of International Trade in CITES-Listed Species Annexes B, C and D JNCC Report No
    Zoonotic potential of international trade in CITES-listed species Annexes B, C and D JNCC Report No. 678 Zoonotic potential of international trade in CITES-listed species Annex B: Taxonomic orders and associated zoonotic diseases Annex C: CITES-listed species and directly associated zoonotic diseases Annex D: Full trade summaries by taxonomic family UNEP-WCMC & JNCC May 2021 © JNCC, Peterborough 2021 Zoonotic potential of international trade in CITES-listed species Prepared for JNCC Published May 2021 Copyright JNCC, Peterborough 2021 Citation UNEP-WCMC and JNCC, 2021. Zoonotic potential of international trade in CITES- listed species. JNCC Report No. 678, JNCC, Peterborough, ISSN 0963-8091. Contributing authors Stafford, C., Pavitt, A., Vitale, J., Blömer, N., McLardy, C., Phillips, K., Scholz, L., Littlewood, A.H.L, Fleming, L.V. & Malsch, K. Acknowledgements We are grateful for the constructive comments and input from Jules McAlpine (JNCC), Becky Austin (JNCC), Neville Ash (UNEP-WCMC) and Doreen Robinson (UNEP). We also thank colleagues from OIE for their expert input and review in relation to the zoonotic disease dataset. Cover Photographs Adobe Stock images ISSN 0963-8091 JNCC Report No. 678: Zoonotic potential of international trade in CITES-listed species Annex B: Taxonomic orders and associated zoonotic diseases Annex B: Taxonomic orders and associated zoonotic diseases Table B1: Taxonomic orders1 associated with at least one zoonotic disease according to the source papers, ranked by number of associated zoonotic diseases identified.
    [Show full text]
  • Biosafety in Microbiological and Biomedical Laboratories—6Th Edition
    Section VIII-A: Bacterial Agents Bacillus anthracis Bacillus anthracis, a Gram-positive, non-hemolytic, and non-motile bacillus, is the etiologic agent of anthrax, an acute bacterial disease among wild and domestic mammals, including humans. Like all members of the genus Bacillus, under adverse conditions, B. anthracis has the ability to produce spores that allow the organism to persist for long periods (i.e., years), withstanding heat and drying, until the return of more favorable conditions for vegetative growth.1 It is because of this ability to produce spores coupled with significant pathogenic potential in humans that this organism is considered one of the most serious and threatening biowarfare or bioterrorism agents.2 Most mammals are susceptible to anthrax; it mostly affects herbivores that ingest spores from contaminated soil and, to a lesser extent, carnivores that scavenge on the carcasses of diseased animals. In the United States, it occurs sporadically in animals in parts of the West, Midwest, and Southwest. Human case rates for anthrax are highest in Africa and central and southern Asia.3 The infectious dose varies greatly from species to species and is route-dependent. The inhalation anthrax infectious dose (ID) for humans has been primarily extrapolated from inhalation challenges of non-human primates (NHPs) or studies done in contaminated wool mills. Estimates vary greatly but the median lethal dose (LD50) is likely within the range of 2,500–55,000 spores.4 It is believed that very few spores (ten or fewer) are required for cutaneous anthrax infection.5 Anthrax cases have been rare in the United States since the first half of the 20th century.
    [Show full text]
  • Colorado Tick Fever in the United States, 2002–2012
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE HHS Public Access provided by CDC Stacks Author manuscript Author ManuscriptAuthor Manuscript Author Vector Borne Manuscript Author Zoonotic Dis Manuscript Author . Author manuscript; available in PMC 2019 December 13. Published in final edited form as: Vector Borne Zoonotic Dis. 2015 May ; 15(5): 311–316. doi:10.1089/vbz.2014.1755. Colorado Tick Fever in the United States, 2002–2012 Stephanie J. Yendell1,2, Marc Fischer1, J. Erin Staples1 1Arboviral Diseases Branch, Centers for Disease Control and Prevention, Fort Collins, Colorado. 2Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia. Abstract Background: Colorado tick fever (CTF) is an acute systemic febrile illness caused by the CTF virus (CTFV). The last national summary of CTF cases in the United States included cases reported through 2001. This study summarizes national surveillance data for CTF from 2002 through 2012 and examines trends in the epidemiology and testing of identified CTF cases. Methods: Because CTF is not nationally notifiable, we identified CTF cases through solicited reports from state health departments and diagnostic laboratory records. For all cases, we collected data on age, sex, county of residence, travel history, symptom onset date, laboratory testing, and clinical outcome. Poisson regression was used to examine trends over time in case counts, and simple linear regression and logistic regression were used to examine trends in case characteristics. Results: From 2002 through 2012, 75 CTF cases were identified with a median of five cases per year (range 3–14). Forty-seven (63%) cases occurred in males and 49 (65%) occurred in people aged ≥ 40 years.
    [Show full text]
  • Laboratory Diagnosis of Arboviruses ESCMID
    Laboratory Diagnosis of Arboviruses ESCMID - Bukarest, Romania March 2018 Chantal Reusken [email protected] Distribution of vector-borne diseases Arboviruses with public health impact have a global and ever changing distribution. Notifications of vector-borne diseases in 2016 on Healthmap.org Syndromes of arboviral diseases 1) Febrile syndrome: . Fever & Malaise . Headache & retro-orbital pain . Myalgia 2) Neurological syndrome: . Meningitis, encephalitis & myelitis . Convulsions & coma . Paralysis 3) Hemorrhagic syndrome: . Low platelet count, liver enlargement . Petechiae . Spontaneous or persistent bleeding . Shock 4) Arthralgia, Arthritis and Rash: . Exanthema or maculopapular rash . Polyarthralgia & polyarthritis Human arboviruses: 6 main virus families Family Genus Species examples Flaviviridae flavivirus Dengue 1-5 (DENV) West Nile virus (WNV) Yellow fever virus (YFV) Zika virus (ZIKV) Tick-borne encephalitis virus (TBEV) Togaviridae alphavirus Chikungunya virus (CHIKV) O’Nyong Nyong virus (ONNV) Mayaro virus (MAYV) Sindbis virus (SINV) Ross River virus (RRV) Barmah forest virus (BFV) Bunyaviridae nairo-, phlebo-, orthobunyavirus Crimean-Congo heamoragic fever Nairoviridae, (CCHFV) Peribunyaviridae, Sandfly fever virus (SFV, TOSV) Phenuiviridae Rift Valley fever virus (RVFV) Oropouche virus (OROV) Reoviridae orbi- en coltivirus Colorado tick-borne fever (CTFV) Overview of spread & syndromes of vector-borne diseases Many diseases display overlapping symptoms and geographical distribution Europe AR NS HS WNV* TBEV* DENV^ East
    [Show full text]